- VIVO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Meridian Bioscience (VIVO) 8-K29 Jul 22Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular AssayFinancial data
Company Profile